myqif myqif myqif
Результаты поиска
Все результаты

    Вступить

    Войти Регистрация
    Ночной режим
    © 2026 myqif
    О нас • CGU • Конфиденциальность • Каталог

    Language

    English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek

Мероприятия

Найти Мероприятия Мои события

Статьи пользователей

Найти Статьи пользователей

Группы

Найти Группы Мои группы

Страницы

Найти Страницы Понравились страницы

Ещё

Популярные записи Найти сообщения
Статьи пользователей Страницы Группы
Мероприятия Смотреть все

Поиск

Знакомьтесь и заводите новых друзей

  • Записей
  • Статьи
  • Пользователи
  • Страницы
  • Группы
  • Мероприятия
  • Clairlabs GenAI поделился ссылкой
    2025-12-12 08:21:20 ·
    From lab bench to autonomous AI agents, blood cancer research and care are evolving fast. Discover how AI-powered diagnostics and treatment support systems are speeding up detection, sharpening therapy insights, and helping clinicians deliver more precise, personalized care — all while maintaining rigorous governance and real-world clinical utility.
    Read the full blog: https://clairlabs.ai/blogs/autonomous-ai-blood-cancer-diagnostics-therapy

    #AIinHealthcare #BloodCancer #AutonomousAI #PrecisionOncology #HealthcareInnovation
    From lab bench to autonomous AI agents, blood cancer research and care are evolving fast. 🧬🤖 Discover how AI-powered diagnostics and treatment support systems are speeding up detection, sharpening therapy insights, and helping clinicians deliver more precise, personalized care — all while maintaining rigorous governance and real-world clinical utility. ➡️ Read the full blog: https://clairlabs.ai/blogs/autonomous-ai-blood-cancer-diagnostics-therapy #AIinHealthcare #BloodCancer #AutonomousAI #PrecisionOncology #HealthcareInnovation
    CLAIRLABS.AI
    Autonomous AI for Blood Cancer: Diagnostics to Therapy
    Enable AI in hematology with cloud NGS, multimodal fusion, federated training, and compliant pipelines that deliver faster, safer leukemia decisions.
    ·3226 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Clairlabs GenAI поделился ссылкой
    2025-12-12 08:19:46 ·
    Lung cancer diagnosis is being revolutionized by AI + Next-Generation Sequencing (NGS)! Explore how cutting-edge tech is boosting early detection, speeding up diagnosis, and helping clinicians deliver targeted care faster. Learn why smarter diagnostics matter now more than ever.
    Check out the full blog: https://clairlabs.ai/blogs/ai-ngs-transform-lung-cancer-diagnosis


    #AIinHealthcare #LungCancer #NGS #PrecisionMedicine #HealthcareInnovation
    Lung cancer diagnosis is being revolutionized by AI + Next-Generation Sequencing (NGS)! 🧬🤖 Explore how cutting-edge tech is boosting early detection, speeding up diagnosis, and helping clinicians deliver targeted care faster. Learn why smarter diagnostics matter now more than ever. ➡️ Check out the full blog: https://clairlabs.ai/blogs/ai-ngs-transform-lung-cancer-diagnosis #AIinHealthcare #LungCancer #NGS #PrecisionMedicine #HealthcareInnovation
    CLAIRLABS.AI
    Transforming Lung Cancer Diagnosis with AI and NGS
    AI and next-gen sequencing are redefining early lung cancer diagnosis, improving detection rates, and reducing costs.
    ·2391 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Clairlabs GenAI поделился ссылкой
    2025-12-12 07:53:04 ·
    Turn complex multi‑omics data into actionable clinical and research insights!
    Meet Impactomics — ClairLabs’ AI‑powered NGS and multi‑omics platform that integrates variant interpretation, automated pipelines, cloud‑native workflows, and explainable AI to accelerate precision medicine, rare‑disease diagnostics, and biomarker discovery at scale. From FASTQ to clinician‑ready reports and translational insights, Impactomics bridges sequencing and real‑world impact with speed, accuracy, and compliance.
    Clair Labs

    Discover Impactomics: https://clairlabs.ai/impactomics

    #MultiOmics #Genomics #AIinHealthcare #PrecisionMedicine #Bioinformatics #HealthcareInnovation
    🧬🚀 Turn complex multi‑omics data into actionable clinical and research insights! Meet Impactomics — ClairLabs’ AI‑powered NGS and multi‑omics platform that integrates variant interpretation, automated pipelines, cloud‑native workflows, and explainable AI to accelerate precision medicine, rare‑disease diagnostics, and biomarker discovery at scale. From FASTQ to clinician‑ready reports and translational insights, Impactomics bridges sequencing and real‑world impact with speed, accuracy, and compliance. Clair Labs 👉 Discover Impactomics: https://clairlabs.ai/impactomics #MultiOmics #Genomics #AIinHealthcare #PrecisionMedicine #Bioinformatics #HealthcareInnovation
    CLAIRLABS.AI
    AI-Powered NGS Platform for Clinical & Multi-Omics Insights
    Accelerate genomic & multi-omics discovery with AI-powered NGS pipelines, automated variant interpretation, unified datasets, and CAP/CLIA-ready workflows for clinical and research teams.
    ·2286 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Xogapep 453 добавлены фото
    2025-11-13 20:29:31 ·
    Looking for reliable solutions in research and diagnostics? You can buy antibodies from trusted suppliers, ensuring high specificity, quality, and reproducibility for your experiments. https://www.betalifesci.com/collections/antibodies
    Looking for reliable solutions in research and diagnostics? You can buy antibodies from trusted suppliers, ensuring high specificity, quality, and reproducibility for your experiments. https://www.betalifesci.com/collections/antibodies
    ·1088 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Tanmay Gupta поделился ссылкой
    2025-07-08 11:59:59 ·
    https://univdatos.com/reports/asia-pacific-cancer-diagnostics-market
    https://univdatos.com/reports/asia-pacific-cancer-diagnostics-market
    UNIVDATOS.COM
    Asia-Pacific Cancer Diagnostics Market- Analysis, Size & Forecast to 2032
    The Asia Pacific Cancer Diagnostics market was valued at USD 22 Billion in 2023 and is expected to grow at a CAGR of 8% during the forecast period (2024-2032)....
    ·1436 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Tanmay Gupta поделился ссылкой
    2025-06-25 09:22:25 ·
    https://univdatos.com/reports/paper-diagnostics-market
    https://univdatos.com/reports/paper-diagnostics-market
    UNIVDATOS.COM
    Paper Diagnostics Market Size, Share, Trends, Growth & Forecast to 2030
    The paper diagnostics market was valued at USD 6,563.8 Million and is expected to grow at a strong CAGR of around 8.2% (2023-2030)...
    ·568 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Tanmay Gupta поделился ссылкой
    2025-06-20 08:28:47 ·
    https://univdatos.com/reports/in-vitro-diagnostics-market-2
    https://univdatos.com/reports/in-vitro-diagnostics-market-2
    UNIVDATOS.COM
    In-Vitro Diagnostics Market Size & Forecast to 2033
    The Global In-Vitro Diagnostics Market was valued at approximately USD 86.2 billion in 2024 and is expected CAGR of around 7.4% from 2025-2033
    ·687 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Tanmay Gupta поделился ссылкой
    2025-06-18 08:42:02 ·
    https://univdatos.com/reports/molecular-diagnostics-market
    https://univdatos.com/reports/molecular-diagnostics-market
    UNIVDATOS.COM
    Molecular Diagnostics Market Report, Size & Trends - 2033
    Molecular Diagnostics Market was valued at approximately USD 16.15 billion in 2024 and is expected to grow at a substantial CAGR of around 7.3% from 2025-2033.
    ·633 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!
  • Tanmay Gupta поделился ссылкой
    2025-06-16 03:51:09 ·
    https://univdatos.com/reports/epigenetics-diagnostics-market
    https://univdatos.com/reports/epigenetics-diagnostics-market
    UNIVDATOS.COM
    Epigenetics Diagnostics Market Size Global Report, 2033
    The Global Epigenetics Diagnostics Market was valued at USD 16,043 million in 2024 and is expected to grow at a strong CAGR of around 17.2% during 2025-2033.
    ·1117 Просмотры
    Войдите, чтобы отмечать, делиться и комментировать!